ginsenoside rh2 has been researched along with olomoucine in 1 studies
| Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (olomoucine) | Trials (olomoucine) | Recent Studies (post-2010) (olomoucine) |
|---|---|---|---|---|---|
| 295 | 1 | 200 | 227 | 0 | 24 |
| Protein | Taxonomy | ginsenoside rh2 (IC50) | olomoucine (IC50) |
|---|---|---|---|
| Chain A, MAP KINASE P38 | Homo sapiens (human) | 27 | |
| Chain A, PROTEIN (MAP KINASE P38) | Homo sapiens (human) | 27 | |
| Chain A, PROTEIN (MAP KINASE P38) | Homo sapiens (human) | 27 | |
| Chain A, Protein (map Kinase P38) | Homo sapiens (human) | 27 | |
| Chain A, Extracellular Regulated Kinase 2 | Rattus norvegicus (Norway rat) | 27 | |
| Chain A, Extracellular Regulated Kinase 2 | Rattus norvegicus (Norway rat) | 27 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 7 | |
| G1/S-specific cyclin-E2 | Homo sapiens (human) | 7.8 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 7 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 6.7875 | |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | 7 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 7 | |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 5.2571 | |
| Cyclin-A2 | Homo sapiens (human) | 7.75 | |
| G1/S-specific cyclin-D1 | Homo sapiens (human) | 7 | |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | 6.4436 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 6.5945 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 7 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 7 | |
| Cyclin-A1 | Homo sapiens (human) | 7.75 | |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 4.6 | |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 5.6667 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 7 | |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 5.2571 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, YH; Lee, SK; Lee, YH; Yoo, KJ | 1 |
1 other study(ies) available for ginsenoside rh2 and olomoucine
| Article | Year |
|---|---|
Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells.
Topics: Apoptosis; Caspase 3; Caspases; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cyclin A; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Endothelium, Vascular; Enzyme Activation; Ginsenosides; Humans; Kinetin; Microtubule-Associated Proteins; Mutation; Protein Serine-Threonine Kinases; Purines; Saponins; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2000 |